Quarterly Transactions Made in Aligos Therapeutics, Inc. (ALGS)
This table provides information about the institutional ownership of Aligos Therapeutics, Inc. (ALGS). The information is specifically focused on institutions that hold shares of Aligos Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 574,224 | 2,511,495 | 3,085,719 | 1,624,401 | 61,513 | 1,685,914 | 1,399,805 | |
| Q3 2021 | 4,311,043 | 1,237,871 | 5,548,914 | 638,059 | 674,884 | 1,312,943 | 4,235,971 | |
| Q4 2021 | 2,858,389 | 178,903 | 3,037,292 | 893,316 | 311,984 | 1,205,300 | 1,831,992 | |
| Q1 2022 | 5,311,800 | 1,930,773 | 7,242,573 | 4,613,815 | 3,870,024 | 8,483,839 | -1,241,266 | |
| Q2 2022 | 986,197 | 3,253,908 | 4,240,105 | 2,360,910 | 4,217,775 | 6,578,685 | -2,338,580 | |
| Q3 2022 | 280,683 | 111,287 | 391,970 | 925,708 | 0 | 925,708 | -533,738 | |
| Q4 2022 | 1,896,202 | 16,420 | 1,912,622 | 683,983 | 0 | 683,983 | 1,228,639 | |
| Q1 2023 | 1,116,943 | 1,842,702 | 2,959,645 | 1,815,369 | 0 | 1,815,369 | 1,144,276 | |
| Q2 2023 | 855,796 | 73,736 | 929,532 | 758,110 | 0 | 758,110 | 171,422 | |
| Q3 2023 | 41,224 | 10,052 | 51,276 | 331,860 | 0 | 331,860 | -280,584 | |
| Q4 2023 | 3,076,623 | 20,032,752 | 23,109,375 | 2,349,007 | 0 | 2,349,007 | 20,760,368 | |
| Q1 2024 | 1,017,718 | 3,363,286 | 4,381,004 | 618,902 | 0 | 618,902 | 3,762,102 | |
| Q2 2024 | 5,449,036 | 926,509 | 6,375,545 | 2,275,847 | 0 | 2,275,847 | 4,099,698 | |